MedPageToday.com

(MedPage Today) -- Doctors a lost voice in abortion political battle, media coverage

(MedPage Today) -- This week's topics also include PT after knee arthroscopy and a measles update

(MedPage Today) -- Higher periconceptional HbA1c levels add to risk in T1D pregnancies

(MedPage Today) -- Safety profile favorable in psoriasis, psoriatic arthritis, and ankylosing spondylitis

(MedPage Today) -- Must reads about the latest news and trends in healthcare careers

(MedPage Today) -- One of the original OB tracker apps is back, but is it worth it?

(MedPage Today) -- Quotable quotes from MedPage Today's sources

(MedPage Today) -- Breast surgeons' group backs risk assessment at age 25 and annual scans at 40

(MedPage Today) -- 40% of women reported zero narcotic use after surgery

(MedPage Today) -- Rasha Al-Lamee, MD, on the sequel to the controversial stent vs sham trial

(MedPage Today) -- But time to recurrence may poorly correlate with survival

(MedPage Today) -- Democrats defend Medicare-for-All proposal

(MedPage Today) -- Contemporary registry data tells a different story than trials

(MedPage Today) -- Fibromyalgia is a term used to describe longstanding musculoskeletal pain for which the cause is unknown. Evidence exists for changes in central nervous system pain processing in people with fibromyalgia, and non-pain symptoms such as stress or sleep dysfunction can also lead to a heightened pain experience. New evidence indicates that peripheral nervous system factors and systemic inflammation may be playing an important role in the production of pain.

(MedPage Today) -- Inferior to standard comparators could lead clinicians to offer unproven care, say researchers

(MedPage Today) -- Findings on BCMA-directed agent provide "benchmark" for future trials

(MedPage Today) -- News and commentary from the endocrinology world

(MedPage Today) -- Add-on to metformin, regardless of basal insulin, boosted glycemic control

(MedPage Today) -- Jeffrey Mechanick, MD, provides some much needed context

(MedPage Today) -- Post hoc analysis of ADVANCE trial supports aiming for lower BP in patients with diabetes, hypertension